Method to stabilize a dietary supplement to facilitate joint health in humans
View Patent ↗The present invention provides for compositions comprising glucosamine wherein the glucosamine has improved and/or enhanced stability. Additionally, the present invention provides for methods of stabilizing compositions for use in preparing an oral dosage form comprising glucosamine.
1. A method for manufacturing a composition comprising a therapeutically effective amount of glucosamine and a therapeutically effective amount of calcium wherein the glucosamine is granulated separately apart from the calcium and the calcium is granulated separately apart from the glucosamine, comprising the steps of (a) providing a first granulation composition comprising glucosamine, a first disintegrant and a first binder and (b) providing a second granulation composition comprising calcium, a second disintegrant and a second binder; and mixing the first granulation and the second granulation, wherein the composition has improved and/or enhanced shelf stability; wherein the calcium is selected from calcium carbonate, dibasic calcium phosphate, tribasic calcium phosphate, calcium gluconate, calcium lactate, calcium citrate, and combinations thereof; and wherein the therapeutically effective amount of glucosamine and the therapeutically effective amount of calcium is administered in a single dose or multiple doses.
2. A method for manufacturing a composition comprising a therapeutically effective amount of glucosamine and a therapeutically effective amount of calcium wherein the glucosamine is granulated separately apart from the calcium and the calcium is granulated separately apart from the glucosamine, comprising the steps of (a) providing a first granulation composition comprising glucosamine, a first disintegrant and a first binder and (b) providing a second granulation composition comprising calcium, a second disintegrant and a second binder; and mixing the first granulation and the second granulation, wherein the first granulation is formed in less than 3% w/w granulation fluid, wherein the calcium is selected from calcium carbonate, dibasic calcium phosphate, tribasic calcium phosphate, calcium gluconate, calcium lactate, calcium citrate, and combinations thereof; further the composition has improved and/or enhanced shelf stability; and wherein the therapeutically effective amount of glucosamine and the therapeutically effective amount of calcium is administered in a single dose or multiple doses.
3. The method according to claim 1 wherein the pH of the first granulation is no greater than 7 and the second granulation composition further comprises at least one vitamin, mineral or active ingredient.
4. The method according to claim 3 wherein the first granulation is formed in less than 3% w/w granulation fluid.
5. The method according to claim 1 further comprising compressing the composition into a tablet or caplet.
6. The method of claim 5 further comprising coating the tablet or caplet with a pharmaceutically acceptable coating material.
7. The method of claim 6 wherein the coating material comprises is polyvinyl alcohol.
8. The method according to claim 1 wherein the first disintegrant is croscarmellose sodium and the first binder is polyvinylpyrrolidone.
9. A method for manufacturing a composition comprising a therapeutically effective amount of glucosamine and a therapeutically effective amount of calcium wherein the glucosamine is granulated separately apart from the calcium and the calcium is granulated separately apart from the glucosamine, comprising the steps of: (a) wet granulating a first granulation composition comprising glucosamine, a first disintegrant and a first binder using less than 3% by weight of granulation fluid, at a pH no greater than 7, and (b) wet granulating a second granulation composition comprising calcium, a second disintegrant, a second binder and at least one vitamin, mineral or active ingredient; and (c) mixing the first granulation and the second granulation, wherein the composition has improved and/or enhanced shelf stability; wherein the calcium is selected from calcium carbonate, dibasic calcium phosphate, tribasic calcium phosphate, calcium gluconate, calcium lactate, calcium citrate, and combinations thereof; and wherein the therapeutically effective amount of glucosamine and the therapeutically effective amount of calcium is administered in a single dose or multiple doses.
10. The method of claim 9 wherein at least one of the first disintegrant or second disintegrant is croscarmellose sodium.
11. The method of claim 10 wherein croscarmellose sodium comprises from about 2% to about 4% of the weight of the first granulation composition.
12. The method of claim 9 wherein at least one of the first binder or second binder is polyvinylpyrrolidone.
13. The method of claim 12 wherein the polyvinylpyrrolidone comprises from about 2% to about 5% of the weight of the first granulation composition.
14. The method of claim 9 further comprising compressing the composition into a tablet or caplet.
15. The method of claim 5 further comprising coating the tablet or caplet with a pharmaceutically acceptable coating material comprising polyvinyl alcohol.
16. The method of claim 1 , wherein multiple doses are two doses, three doses, four doses, or five doses.
17. The method of claim 2 , wherein multiple doses are two doses, three doses, four doses, or five doses.
18. The method of claim 9 , wherein multiple doses are two doses, three doses, four doses, or five doses.